๐
Akantior
polihexanide
Acanthamoeba Keratitis
โ
Authorised
โ
No active alerts
This medicine has no ongoing shortages, safety letters or recalls.
What it's used for
Akantior is indicated for the treatment of Acanthamoeba keratitis in adults and children from 12 years of age.
โ ๏ธ Patient safety
No
Official EMA page
https://www.ema.europa.eu/en/medicines/human/EPAR/akantior